Analyst Price Target is $85.00
▲ +1,203.68% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Helius Medical Technologies in the last 3 months. The average price target is $85.00, with a high forecast of $85.00 and a low forecast of $85.00. The average price target represents a 1,203.68% upside from the last price of $6.52.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Helius Medical Technologies. This Buy consensus rating has held steady for over two years.
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.